Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase

Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase

US Patent 10246461 · Granted Apr 2, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase2022
Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase2022
Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase2022
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof2021
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof2020
Method of expressing a G-protein coupled receptor protein2019
Nucleic acid sequence encoding a fusion protein2018
Small molecule compound and synthesizing method and uses thereof2018
Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioa2018
Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioat2017
Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioat2017
Fusion expression of G-protein coupled receptor2017